CoChat

Deletion of the Androgen Receptor in Adipose Tissue in Male Mice Elevates Retinol Binding Protein 4 and Reveals Independent Effects on Visceral Fat Mass and on Glucose Homeostasis

Open access
McInnes, Kerry J., Smith, Lee B., Hunger, Nicole I., Saunders, Philippa T.K., Andrew, Ruth, Walker, Brian R. · 2012 · Diabetes
Cited by 121

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Testosterone deficiency is epidemic in obese ageing males with type 2 diabetes, but the direction of causality remains unclear. Testosterone-deficient males and global androgen receptor (AR) knockout mice are insulin resistant with increased fat, but it is unclear whether AR signaling in adipose tissue mediates body fat redistribution and alters glucose homoeostasis. To investigate this, mice with selective knockdown of AR in adipocytes (fARKO) were generated. Male fARKO mice on normal diet had reduced perigonadal fat but were hyperinsulinemic and by age 12 months, were insulin deficient in the absence of obesity. On high-fat diet, fARKO mice had impaired compensatory insulin secretion and hyperglycemia, with increased susceptibility to visceral obesity. Adipokine screening in fARKO mice revealed a selective increase in plasma and intra-adipose retinol binding protein 4 (RBP4) that preceded obesity. AR activation in murine 3T3 adipocytes downregulated RBP4 mRNA. We conclude that AR signaling in adipocytes not only protects against high-fat diet–induced visceral obesity but also regulates insulin action and glucose homeostasis, independently of adiposity. Androgen deficiency in adipocytes in mice resembles human type 2 diabetes, with early insulin resistance and evolving insulin deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-1136

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 34

  1. Hamilton, 2011, Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy, Clin Endocrinol (Oxf), 74, 377, 10.1111/j.1365-2265.2010.03942.x · DOI · Paper page
  2. Jones, 2010, Testosterone deficiency: a risk factor for cardiovascular disease?, Trends Endocrinol Metab, 21, 496, 10.1016/j.tem.2010.03.002 · DOI · Paper page
  3. Joyner, 2002, Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes, Horm Metab Res, 34, 223, 10.1055/s-2002-32144 · DOI · Paper page
  4. Sato, 2003, Late onset of obesity in male androgen receptor-deficient (AR KO) mice, Biochem Biophys Res Commun, 300, 167, 10.1016/S0006-291X(02)02774-2 · DOI · Paper page
  5. Yu, 2008, Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue, Endocrinology, 149, 2361, 10.1210/en.2007-0516 · DOI · Paper page
  6. Lin, 2008, Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor, Hepatology, 47, 1924, 10.1002/hep.22252 · DOI · Paper page
  7. Eguchi, 2011, Transcriptional control of adipose lipid handling by IRF4, Cell Metab, 13, 249, 10.1016/j.cmet.2011.02.005 · DOI · Paper page
  8. De Gendt, 2004, A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis, Proc Natl Acad Sci U S A, 101, 1327, 10.1073/pnas.0308114100 · DOI · Paper page
  9. Welsh, 2009, Androgen action via testicular peritubular myoid cells is essential for male fertility, FASEB J, 23, 4218, 10.1096/fj.09-138347 · DOI · Paper page
  10. Morton, 2001, Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice, J Biol Chem, 276, 41293, 10.1074/jbc.M103676200 · DOI · Paper page
  11. Winzell, 2004, The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes, Diabetes, 53, S215, 10.2337/diabetes.53.suppl_3.S215 · DOI · Paper page
  12. Corker, 1978, A radioimmunoassay for testosterone in various biological fluids without chromatography, J Steroid Biochem, 9, 373, 10.1016/0022-4731(78)90634-9 · DOI · Paper page
  13. De Sousa Peixoto, 2008, Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo, Endocrinology, 149, 1861, 10.1210/en.2007-1028 · DOI
  14. McInnes, 2006, Regulation of adenosine 5′,monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state, Endocrinology, 147, 5907, 10.1210/en.2006-0879 · DOI · Paper page
  15. Bojesen, 2006, The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism, Diabetes Care, 29, 1591, 10.2337/dc06-0145 · DOI · Paper page
  16. Basaria, 2006, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy, Cancer, 106, 581, 10.1002/cncr.21642 · DOI · Paper page
  17. Zitzmann, 2003, The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men, Diabetologia, 46, 31, 10.1007/s00125-002-0980-9 · DOI · Paper page
  18. Lin, 2005, Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor, Diabetes, 54, 1717, 10.2337/diabetes.54.6.1717 · DOI · Paper page
  19. Kobayashi, 2005, Adipokines: therapeutic targets for metabolic syndrome, Curr Drug Targets, 6, 525, 10.2174/1389450054021972 · DOI · Paper page
  20. Yatagai, 2003, Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus, Metabolism, 52, 1274, 10.1016/S0026-0495(03)00195-1 · DOI · Paper page
  21. Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697 · DOI · Paper page
  22. Blüher, 2002, Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance, Dev Cell, 3, 25, 10.1016/S1534-5807(02)00199-5 · DOI · Paper page
  23. Semple, 2006, Elevated plasma adiponectin in humans with genetically defective insulin receptors, J Clin Endocrinol Metab, 91, 3219, 10.1210/jc.2006-0166 · DOI
  24. Lanfranco, 2004, Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy, Clin Endocrinol (Oxf), 60, 500, 10.1111/j.1365-2265.2004.02007.x · DOI · Paper page
  25. Graham, 2005, Serum retinol binding protein (RBP4) is a novel adipocyte-secreted protein elevated in obesity and type 2 diabetes that contributes to insulin resistance, Diabetes, 54, A5
  26. Cho, 2006, Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes, Diabetes Care, 29, 2457, 10.2337/dc06-0360 · DOI · Paper page
  27. Klöting, 2007, Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass, Cell Metab, 6, 79, 10.1016/j.cmet.2007.06.002 · DOI · Paper page
  28. Graham, 2007, Serum retinal binding protein (RBP4) levels predict intraabdominal fat mass, Diabetes, 56, A365
  29. Tan, 2007, Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids, J Clin Endocrinol Metab, 92, 2764, 10.1210/jc.2007-0091 · DOI · Paper page
  30. Ost, 2007, Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes, FASEB J, 21, 3696, 10.1096/fj.07-8173com · DOI · Paper page
  31. Danielsson, 2005, Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes, FEBS J, 272, 141, 10.1111/j.1432-1033.2004.04396.x · DOI
  32. Wu, 2009, RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans, J Lipid Res, 50, 1479, 10.1194/jlr.P900014-JLR200 · DOI · Paper page
  33. Takebayashi, 2007, Retinol binding protein-4 levels and clinical features of type 2 diabetes patients, J Clin Endocrinol Metab, 92, 2712, 10.1210/jc.2006-1249 · DOI · Paper page
  34. Lee, 2007, Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents, Metabolism, 56, 327, 10.1016/j.metabol.2006.10.011 · DOI

Cited by

See all 121

Metadata

Authors
McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R.
Venue
Diabetes
Published
2012-04-13
Volume
61
Issue
5
Pages
1072-1081
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2111061353
Cited by
121
References
11
FWCI
7.32
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deletion of the Androgen Receptor in Adipose Tissue in Male Mice Elevates Retinol Binding Protein 4 and Reveals Independent Effects on Visceral Fat Mass and on Glucose Homeostasis. https://app.cochat.ai/papers/10.2337/db11-1136
The paper
McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R. (2012). Deletion of the Androgen Receptor in Adipose Tissue in Male Mice Elevates Retinol Binding Protein 4 and Reveals Independent Effects on Visceral Fat Mass and on Glucose Homeostasis. Diabetes. https://doi.org/10.2337/db11-1136

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.